Sitagliptin

JANUVIA, ZITUVIO

Dipeptidyl Peptidase 4 Inhibitor

NADAC/unit $10.0412

No Shortage Tier 1: 57.4% PA Req: 0.9% 3 Manufacturers 9 ANDAs

ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycem....

vs. brand JANUVIA: Generic saves up to -0% per unit

Covered Lives

Generic Manufacturers

APOTEX INCAZURITY PHARMACEUTICALS INCMERCK SHARP AND DOHME CORPSANDOZ INCWATSON LABORATORIES INCZYDUS LIFESCIENCES GLOBAL FZE

Explore in the Ecosystem

rxsaver.aiCompare prices for Sitagliptin drfinder.aiFind doctors who prescribe Sitagliptin rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Sitagliptin

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.